Skip to main content
Equibles
COR logo

COR · Cencora, Inc. · Metrics

Track COR — free

Use COR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$300.25 -7.35 (-2.39%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$57.74B
Shares
190.83M
Volume · Sep 30 1.81M Avg daily vol (3M) 1.38M

COR metrics

91 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$300.25
Market cap
$57.74B

Price action

20 metrics
Price change (1W)
-2.2%
Price change (30D)
-4.9%
Price change (3M)
+8.7%
Price change (6M)
-2.1%
Price change (YTD)
-8.9%
Price change (1Y)
-0.2%
Trailing year
Price change (5Y)
+151.1%
52-week high
$374.75
52-week low
$252.74
Change from 52-week high
-17.9%
Change from 52-week low
+21.7%
Annualized volatility
30.9%
Annualized volatility (3M)
27.2%
Beta
-0.2
RSI (14D)
41.7
Price vs SMA 50
-3.1%
Price vs SMA 200
-3.5%
Avg volume (3M)
1.38M
Relative volume
0.9
Average dollar volume
$431.79M

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
190.83M

Valuation

12 metrics
P / E (TTM)
22.8
Trailing earnings · reciprocal yield 4.4%
PEG ratio
1.9
EV / revenue
0.2×
reciprocal yield 499.3%
EV / EBITDA
16.3×
reciprocal yield 6.1%
EV / EBIT
21.9×
reciprocal yield 4.6%
P / sales
0.2×
reciprocal yield 576.3%
P / book
18.9
reciprocal yield 5.3%
FCF yield
7.0%
TTM · current market cap
Buyback yield
0.8%
P / FCF
14.2
reciprocal yield 7.0%
P / operating cash flow
12.0
reciprocal yield 8.3%
Earnings yield
4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
30.2×
reciprocal yield 3.3%
P / E historical average (5Y)
25.9×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 524.0%
EV / revenue historical average (5Y)
0.2×
reciprocal yield 574.7%
EV / EBIT historical average (3Y)
22.6×
reciprocal yield 4.4%
EV / EBIT historical average (5Y)
19.5×
reciprocal yield 5.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
17.8%
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
4.0%
Operating margin
0.9%
Trailing 12 months
Net margin
0.8%
Gross profit (TTM)
$13.22B
Operating profit (TTM)
$3.04B
Net income (TTM)
$2.62B
Trailing 12 months
Diluted EPS (TTM)
$13.47
FCF margin
1.2%
Effective tax rate
26.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.78

Growth

11 metrics
Revenue growth YoY
+5.1%
Year over year
Net income growth YoY
+11.1%
Revenue (TTM)
$332.77B
Trailing 12 months
EPS growth YoY
+11.9%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.4%
Revenue CAGR (5Y)
+11.1%
EPS CAGR (3Y)
-0.3%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+13.3%
FCF CAGR (5Y)
+11.8%

Quality

14 metrics
Return on equity
86.0%
Return on assets
3.1%
Debt / equity
3.8
Current ratio
0.9
EBITDA (TTM)
$4.08B
Free cash flow (TTM)
$4.06B
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
2.2
Return on invested capital
18.6%
Trailing 12 months
Net cash
−$8.91B
Latest balance sheet
Cash & equivalents
$2.82B
Total assets
$83.81B
Total debt
$11.72B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$4.82B
Capital expenditures (TTM)
$760.85M
R&D (TTM)
—
SG&A (TTM)
$7.65B
Stock compensation (TTM)
$148.73M
R&D / revenue
—
Stock compensation / revenue
0.0%

Ownership (13F)

3 metrics
13F filers
1,355
13F filer change QoQ
-90
Institutional ownership
96.5%

Short interest

3 metrics
Short interest
2.3%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.39M
Insider-sentiment score
30 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1140859 CUSIP 03073E105 13F (30d) 42 filings 20 filers Visit website Investor relations